Efficacy of Physiotherapy on the Health and Quality of Life of the Rheumatic Patient
Phase 2
- Conditions
- Rheumatic Arthritis
- Interventions
- Other: PhysiotherapyOther: Wait list control
- Registration Number
- NCT02020668
- Lead Sponsor
- Macmillan Research Group UK
- Brief Summary
Despite leading cause of morbidity, treatment strategies for Rheumatic diseases are geared almost exclusively toward medical-pharmacological area away from offering the patient the possibility of an interdisciplinary approach to their disease.
Present study test whether treatment of physiotherapy reduces stiffness and pain inherent in rheumatic disease and improve their quality of life related to health.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 82
Inclusion Criteria
- Patients older than 18 years
- History of Rheumatoid Arthritis (RA) symptoms for less than 7 years
- Had RA by American College of Rheumatology (ACR) criteria
- ACR functional RA class I, II or III
- Hemoglobin more than 8g/dL without evidence of active bleeding
- Positive for rheumatoid factor (RF) or anti cyclic citrullinated protein
- standard conventional medicine were allowed within the approved dosage regimen
Exclusion Criteria
- connective tissue disease
- any other alternative or complementary medicine with in last 3 months.
- corticosteroid, disease modifying medicines
- Poorly controlled diabetes, hypertension, hepatitis, cardiac disease, liver diseases, carcinoma, drug abuse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Physiotherapy Physiotherapy Physiotherapy included joint protection strategies, performance of therapeutic exercises and patient education. Wait list control Wait list control Wait list control received standard care and were invited to join the physiotherapy once intervention period is finished.
- Primary Outcome Measures
Name Time Method Pain Change from baseline in Numerical Scale Downie at 16 weeks
- Secondary Outcome Measures
Name Time Method Quality of Life Change from Baseline in Short Form (SF) 36 at 16 weeks
Trial Locations
- Locations (1)
Life Line Hospital
🇮🇳Sikar, Rajasthan, India